A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

charite.de Background Anti-NMDA receptor (NMDAR) encephalitis is a recently characterised autoimmune disorder mainly affecting young women. Although the clinical features of the acute disease are well ...

EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ: NRXP) will appear on ...

Pre-planned Phase 3 Reliance II interim analysis, anticipated by YE 2024, could represent an important de-risking event for REL-1017 and the ...

J.P. Morgan analyst Tessa Romero downgraded the rating on Neumora Therapeutics, Inc. (NMRA – Research Report) to a Hold today, setting a ...

WARNING: All articles and photos with a byline or photo credit are copyrighted to the author or photographer. You may not use ...

Amalia Romero's life changed in August when she woke up in a panic, immediately asking her sister to drive her to urgent care ...

Older hospitalized adults with both magnesium and calcium deficiencies exhibit significantly lower cognitive function, highlighting the need for nutrient monitoring in aging populations.

It works on the N-methyl-D-aspartate (NMDA) receptor, an ionotropic glutamate receptor in the brain, and is used alongside a newly prescribed oral antidepressant. It works by restoring nerve cell ...